RXi, UMass To Study Age-Related Disease Treatments
by Worcester Business - January 14, 2010 6:10pm
Worcester-based RXi Pharmaceuticals Corp. has inked a collaboration agreement with the University of Massachusetts Medical School to research how RXi’s RNAi technology can be applied to age-related diseases.
More Worcester News